Search
Search Results
##search.searchResults.foundPlural##
-
ESCHERICHIA COLI: AN IMPORTANT PATHOGEN IN PATIENTS WITH HEMATOLOGIC MALIGNANCIES
2316PDF: 766HTML: 2150Untitled: 257Untitled: 177Untitled: 209Untitled: 185Untitled: 200Untitled: 211Untitled: 216 -
AN INEXPENSIVE CLINICAL-LABORATORY NOMOGRAM TO PREDICT POST-TREATMENT LUNG DESTRUCTION IN PULMONARY TUBERCULOSIS
701PDF: 353Suppl. Files: 90Html: 75 -
TRANSCRIPTOME ANALYSIS OF BETA-CATENIN-RELATED GENES IN CD34+ HAEMATOPOIETIC STEM AND PROGENITOR CELLS FROM PATIENTS WITH AML Transcriptome analysis of beta-catenin-related genes in AML
1172PDF: 1225Suppl. Files: 592HTML: 100 -
Magnusiomyces capitatus Breakthrough Infection in Allogeneic Hematopoietic Cell Transplant Recipients Receiving Echinocandin Prophylaxis: Clinical Features, Management, and Review of the Literature
80PDF: 91Suppl. Files: 14Html: 19Html Suppl. Files: 9 -
Brief tale of a bacteraemia by Rhodococcus equi with concomitant lung mass: what came first, the chicken or the egg?
1477PDF: 869HTML: 8676Fig 3 Savini: 207Fig 2 Savini: 211Fig 1 Savini Chest TC: 214Author letter to referees: 218 -
RECENT ADVANCES IN THE DEFINITION OF THE MOLECULAR ALTERATIONS OCCURRING IN MULTIPLE MYELOMA MOLECULAR ALTERATIONS OCCURRING IN MM
1375PDF: 1129HTML: 260 -
“IDENTIFYING HIGH-RISK CHRONIC LYMPHOCYTIC LEUKEMIA: A PATHOGENESIS-ORIENTED APPRAISAL OF PROGNOSTIC AND PREDICTIVE FACTORS IN PATIENTS TREATED WITH CHEMOTHERAPY WITH OR WITHOUT IMMUNOTHERAPY.”
4066PDF: 1105HTML: 3901Untitled: 193Cneo. Fig.1: 132Untitled: 125Untitled: 150Untitled: 160 -
MANAGEMENT OF HBV INFECTION DURING IMMUNOSUPPRESIVE TREATMENT
896PDF: 504HTML: 1314 -
-
THE TRAGEDY CAUSED BY FAKE ANTIMALARIAL DRUGS
2857PDF: 1119HTML: 1962 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3442PDF: 1301HTML: 8397 -
-
-
CONTINUOUS CULTURES OF PLASMODIUM FALCIPARUM ESTABLISHED IN TANZANIA FROM PATIENTS WITH ACUTE MALARIA In vitro Malaria cultures
1937PDF: 619HTML: 261 -
CHIMERIC ANTIGEN RECEPTOR T CELLS FOR THE TREATMENT OF MULTIPLE MYELOMA CAR T Cells and Myeloma Treatment
1871PDF: 921HTML: 1490 -
ASSOCIATION BETWEEN PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE INFECTION PRE-ADMISSION 48-HOUR FEVER BURDEN AND OUTCOMES IN PEDIATRIC MYCOPLASMA PNEUMONIAE
254PDF: 376Suppl. Files: 71HTML: 136 -
GLUCOSE METABOLISM AND INSULIN RESPONSE TO ORAL GLUCOSE TOLERANCE TEST (OGTT) IN PREPUBERTAL PATIENTS WITH TRANSFUSION DEPENDENT Β-THALASSEMIA (TDT): A LONG-TERM RETROSPECTIVE ANALYSIS Long-term retrospective analysis of glucose homeostasis in children with transfusion dependent β-thalassemia
1929PDF: 599HTML: 253 -
INTEREST IN DETERMINING THE CD34+ CD38- PHENOTYPE IN THE DIAGNOSIS AND PROGNOSIS OF ACUTE LEUKEMIA IN ABIDJAN – CÔTE D’IVOIRE
2076PDF: 792HTML: 725Table1: patient's characteristics: 180Table 2: profile of each patient: 208 -
Acquired Hemophilia A successfully treated with rituximab
2199PDF: 1189HTML: 1518Figure 1: 223 -
Ponatinib induced improvement of cutaneous lesions associated to accelerated phase of Ph-positive chronic myeloid leukemia
2973PDF: 730HTML: 1966figure 1: 205figure 2: 202 -
TUBERCULOSIS IN TROPICAL AREAS AND IMMIGRANTS
3488PDF: 1385HTML: 6347 -
SPHINGOMONAS PAUCIMOBILIS INFECTIONS IN CHILDREN: NOSOCOMIAL VERSUS COMMUNITY ACQUIRED INFECTIONS
1879PDF: 1061HTML: 2081cover: 214Table 1. Co-morbidities associated with Sphingomonas paucimobilis infections.: 218Figure 1. The antimicrobial susceptibility patterns of Sphingomonas paucimobilis isolated from clinical specimens: 1745title page: 214 -
CAR-T CELL THERAPY IN LARGE B CELL LYMPHOMA CAR-T; Large B Cell Lymphoma; Salvage Therapy,
3897PDF: 1550HTML: 351 -
SIMILARITIES OF ELDERLY AND THERAPY-RELATED AML
3804PDF: 945HTML: 6882 -
WALDENSTROM’S MACROGLOBULINEMIA: AN UPDATE
7890PDF: 2498HTML: 2123Table 1.: 259Table 2.: 266Table 3.: 244Table 4.: 241 -
A rare case of multidrug resistant Leclercia adecarboxylata catheter-related bloodstream infection and an updated brief literature review Leclercia adecarboxylata catheter-related bloodstream infection.
956PDF: 609HTML: 216 -
Concordance Rate of Fasting Plasma Glucose (PG) and 2-hour PG post Oral Glucose Tolerance Test (OGTT) in Patients with new diagnosis of Thalassemia-Related Diabetes Mellitus (Th-RDM):Implications for Clinical Practice OGTT concordance rate in thalassemia major
802PDF: 605Html: 148 -
HIGHLIGHTS ON THE CONTRIBUTION OF GUT MICROBIOTA TO IMMUNE-MEDIATED DISEASES IN CHILDHOOD Gut microbiota in childhood immune-mediated diseases
1196PDF: 873HTML: 274 -
COULD PLASMA GLUCOSE (PG) INCREMENT (PG %) EXPAND THE CLINICAL WEIGHT OF OGTT? PRELIMINARY FINDINGS IN 19 TDT PATIENTS (Β-TDT) WITH NORMAL GLUCOSE TOLERANCE Plasma glucose (PG) increment (PG %) and pancretic β-cell dysfunction in thalassemia
818PDF: 692HTML: 133







